We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Neuroscience and Robotics Return Limb Function

By HospiMedica staff writers
Posted on 28 Nov 2007
A new non-invasive neurorobotic system, combining advances in neuroscience and robotics, is being used to restore independence to individuals after loss of neurological function or atrophy.

The e100 NeuroRobotic System is a user-controlled, wearable robotic brace designed to non-invasively treat arm dysfunction cause by stroke. More...
Clinically shown to improve mobility in patients ranging from 4 to 21 years after stroke onset, the robotic brace helps patients relearn how to move by enabling them to self-initiate and control movement of hemiparetic (partially paralyzed) arms using their biological signals. No electrical stimulation or invasive procedures are employed to help patients relearn how to control their weakened muscles and achieve more normative movement patterns.

When a patient's electrical muscle activity signal fires in response to attempted movement, the device senses the signal from the skin's surface. The system then employs advanced robotics to reward the patient with feedback in the form of actual motion. Since the presence (or absence) of a person's Electromyography (EMG) signal determines motion, patients using the Myomo device may stop and re-adjust positioning during real-time execution of a targeted exercise as they work toward muscle re-education training. Adjustable system parameters allow therapists to set and vary assistance levels in proportion to patient ability. The e100 NeuroRobotic System, a product of Myomo (Boston, MA, USA) received a Best of What's New Popular Science magazine 2007 award.

"Everyone at Myomo is very excited to be recognized by Popular Science as a company that is revolutionizing healthcare with NeuroRobotic's technology,” said Thomas Glover, CEO of Myomo.


Related Links:
Myomo

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.